Insider Transactions Reported by 21 Insiders of SpringWorks Therapeutics, Inc.

Location
Stamford, CT

There are no Buy or Sell transactions made by insiders since 06 Mar 2025

SpringWorks Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
STEPHEN P. SQUINTO Director, 10%+ Owner $262,384,838 19 May 2022
ORBIMED ADVISORS LLC 10%+ Owner $232,561,438 12 Sep 2022
Bain Capital Life Sciences Investors, LLC 10%+ Owner $200,690,112 10 Aug 2021
Jeffrey Schwartz Director $128,405,735 24 May 2023
L. Mary Smith Chief Development Officer $9,691,565 04 Jan 2024
Michael F. Burgess Head of Research & Development $2,059,224 18 Jul 2022
Badreddin Edris Chief Operating Officer $0 01 Jul 2025
Bhavesh Ashar Chief Commercial Officer $0 01 Jul 2025
Tai-An Lin Chief Scientific Officer $0 01 Jul 2025
CARLOS ALBAN Director $0 01 Jul 2025
Julie Hambleton Director $0 01 Jul 2025
Alan Fuhrman Director $0 01 Jul 2025
James Cassidy Chief Medical Officer $0 01 Jul 2025
DANIEL LYNCH Director $0 01 Jul 2025
Daniel Pichl Chief People Officer $0 01 Jul 2025
MARTIN MACKAY Director $0 01 Jul 2025
Freda Lewis-Hall Director $0 01 Jul 2025
Saqib Islam Chief Executive Officer, Director $0 01 Jul 2025
Francis I. Perier Jr. Chief Financial Officer $0 01 Jul 2025
Herschel S. Weinstein General Counsel & Secretary $0 01 Jul 2025
Michael Nofi Chief Accounting Officer $0 01 Jul 2025

Recent Insider Transactions by Companies or Individuals for SpringWorks Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.